Detailed description of the main indications and patient scope of estramustine (Adelex)

Estramustine (Estramustine) is an anti-cancer drug used for tumor treatment. It mainly works through the combination of estrogen part and nitrogen mustard analogues. Its pharmacological mechanism involves inhibiting tubulin polymerization of tumor cells, thereby preventing cell division and proliferation and achieving anti-tumor effects. Estramustine not only has the direct cytotoxic effect of chemotherapy drugs, but also improves the targeting of drugs in prostate tissue through estrogen effects, thereby enhancing the efficacy.

Clinically, the main indication for estramustine is advanced or metastatic prostate cancer, especially for patients who have failed to respond to traditional endocrine therapy (such as androgen blockade). For these patients, estramustine can delay tumor progression, improve survival time, and improve quality of life to a certain extent. In addition, some clinical studies are also exploring its potential application in other androgen-dependent tumors, but it is currently mainly approved for the treatment of prostate cancer.

Before using estramustine, patients need to undergo detailed evaluation, including blood parameters, liver and kidney function, and cardiovascular status. Because estramustine has estrogenic activity and may increase the risk of thrombosis, it should be used with caution or under strict monitoring in patients with a history of thrombosis or severe cardiovascular disease. At the same time, patients should strictly control the dosage and taking period according to medical instructions to ensure the efficacy and safety of the drug.

In conclusion, estramustine is indicated for patients with advanced or metastatic prostate cancer, especially those who have failed to respond to conventional hormone therapy. Reasonable selection of applicable groups, standardized medication use, and close monitoring of efficacy and side effects are the keys to ensuring the therapeutic effect of estramustine. Patients should use it under the guidance of a professional doctor and avoid adjusting the dosage or stopping the medication on their own.

Reference materials:https://www.drugs.com/